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Summary
Objectives: In this study, we assessed the antimicrobial susceptibility patterns and prevalence of
methicillin resistance among Staphylococcus aureus isolates from hospital and community
sources in southern Jamaica.
Methods: Eighty isolates of S. aureus obtained from hospital and community-based patients with
staphylococcal infections were collected, and antimicrobial susceptibilities were determined by
disk diffusion.
Results: While all specimens yielded isolates, multidrug-resistant isolates were obtained only
from urine, high vaginal swab, abscess aspirate, and catheter tip samples. The overall prevalence
of methicillin-resistant S. aureus (MRSA) was 23%. The proportions of MRSA isolated from hospital
sources (18/39) and community sources were 46% and 0%, respectively ( p < 0.05). The pattern of
antibiotic susceptibility of S. aureus differed significantly between MRSA and methicillin-sus-
ceptible (MSSA) isolates. For MRSA isolates, multiple-drug resistance was common and only few
antibiotics were active against these isolates. However, no MRSA was resistant to vancomycin.
Except for penicillin and to some extent co-trimoxazole (trimethoprim—sulfamethoxazole), most
MSSA isolates were susceptible to nearly all antimicrobial agents used in this study.
Conclusions: This is the first report of MRSA from this region of Jamaica. Because methicillin
resistance is associated with multiple-drug resistance in S. aureus, it is imperative that surveil-
lance initiatives be focused on both the hospital and community in order to monitor and limit the
spread of this organism.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +1 876 927 2290; fax: +1 876 977 7852.
E-mail address: paul.brown@uwimona.edu.jm (P.D. Brown).
1201-9712/$32.00 # 2006 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2006.04.005Introduction
Staphylococcus aureus is among the most important nosoco-
mial pathogens because of both the diversity and the severityPublished by Elsevier Ltd. All rights reserved.
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Table 1 Distribution of positive specimens among hospital
and community sources
Specimen Hospital
samples
Community
samples
n % n %
Urine 9 23.1 14 34.1
High vaginal swabs 4 10.3 8 19.5
Urethral swabs 2 5.1 3 7.3
Eye swabs 0 0 1 2.4
Wound swabs 1 2.6 6 14.6
Vaginal swabs 0 0 2 4.9
Skin swabs 1 2.6 0 0
Peritoneal aspirates 1 2.6 0 0
Knee aspirates 1 2.6 0 0
Semen 0 0 3 7.3
Wound abscess 3 7.7 3 7.3
Abdominal abscess 3 7.7 0 0
Cervical abscess 1 2.6 0 0
Blood 4 10.3 1 2.4
CSF 1 2.6 0 0
Catheter tip 3 7.7 0 0
Catheter urine 2 5.1 0 0
Sputum 3 7.7 0 0
Total 39 41
CSF, cerebrospinal fluid.of the infections it causes, including superficial, deep skin, and
soft-tissue infections, endocarditis, andbacteremia, aswell as
a variety of toxin-mediated diseases such as gastroenteritis,
staphylococcal scalded-skin syndrome, and toxic shock syn-
drome.1,2Methicillin (oxacillin)-resistant S. aureus (MRSA)was
first described in 1961,3 and since then has become a signifi-
cant pathogen innosocomial infections.4 Community-acquired
MRSA is now increasingly recognized5 with many of these
infections occurring in patients with no prior hospital expo-
sure. These community-based infections have been reported
in patients from both rural and urban settings.6—8 For clin-
icians, the spread of these methicillin-resistant strains has
been critical as the therapeutic outcome of infections that
result fromMRSA isworse that those frommethicillin-sensitive
strains (MSSA).9 Consequently, knowledge of community and
nosocomial antimicrobial susceptibility profiles of S. aureus
would prevent abuse of glycopeptides.
In Jamaica, health services are delivered through four
semi-autonomous regional health authorities that have
direct management responsibility within a geographically
defined region.10 Antibiotic treatment recommended locally
for urinary tract infections include the penicillins (penicillin,
ampicillin, amoxicillin, and oxacillin) and trimethoprim—
sulfamethoxazole (co-trimoxazole) as primary therapy, fol-
lowed by the first and second generation cephalosporins, and
the quinolones. In other infections, tetracycline, cefaclor,
clindamycin, and trimethoprim—sulfamethoxazole are the
first drugs of choice, followed by erythromycin, gentamicin,
and ciprofloxacin.
S. aureus shows acquired resistance to many structurally
unrelated antibiotics and as rapidly as new antibiotics are
introduced, S. aureus have developed resistance mechan-
isms.11,12 Because of these facts, it is important to isolate and
identify the offending strain in order for appropriate anti-
biotic therapy to be initiated. The aim of this study was to
assess the antimicrobial susceptibility patterns and preva-
lence of methicillin resistance among Staphylococcus aureus
isolates from hospital and community sources in southern
Jamaica.
Materials and methods
Clinical specimens and isolations
Non-duplicate hospital and community specimens of high
vaginal swabs, blood, urine, aspirates, sputum, wound and
abscess swabs, cerebrospinal fluid, and semen submitted by
patients being investigated for staphylococcal infections
between May and August 2002 were analyzed in this study.
The clinical specimens were brought without delay to the
laboratory and were processed according to standard tech-
niques.13 Hospital specimens were from in-patients at the
Mandeville Regional Hospital, Manchester, which serves the
parishes of Manchester, Clarendon, and St. Elizabeth. Com-
munity specimens were from persons seen at private primary
care centers in Manchester and specimens referred to the
laboratory. During history-taking at these primary care cen-
ters, patients were assessed as to whether they had pre-
viously been hospitalized for a medical condition.
Unless otherwise noted, bacteria were grown at 37 8C
in Luria—Bertani medium (Oxoid, Hampshire, UK) or inMueller—Hinton broth or agar (BD Biosciences, Cockeysville,
MD, USA). Isolates were identified as Staphylococcus aureus
based on conventional bacteriological tests, which included
Gram staining, catalase test, tube coagulase test using rabbit
plasma (Difco Laboratories, USA), and the Pastorex Staph-
plus latex agglutination test (Bio-Rad, CA, USA), including
appropriate controls according to the manufacturer’s
instructions.
Antibiotic susceptibility testing
Susceptibility to clindamycin, gentamicin, penicillin, oxa-
cillin, erythromycin, ciprofloxacin, trimethoprim—sulfa-
methoxazole, tetracycline, vancomycin, chloramphenicol,
and nitrofurantoin was determined by the standard disc
diffusion technique in accordance with the guidelines of
the National Committee for Clinical Laboratory Standards.14
Cartridges of antimicrobial-containing discs were obtained
from Oxoid, Mast Diagnostics (Merseyside, UK), BD Bios-
ciences, or Janssen—Cilag (Puebla, Mexico), stored
between 4 and 20 8C, and allowed to come to room
temperature prior to use. Mueller—Hinton plates were incu-
bated at 35 8C for 16—18 h after inoculation with organisms
and placement of discs, and zones of inhibition were mea-
sured. Plates with oxacillin and vancomycin were incubated
for 24 h. S. aureus ATCC 25923 and 29213 were used as
reference strains.
Statistical analysis
Statistical analysis was performed using the x2 test. Differ-
ences were considered significant at p  0.05.
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Table 2 Number and percentages of Staphylococcus aureus isolates resistant to antimicrobial agents by NCCLS diffusion method
Antibiotic All isolates
(n = 80)
Isolates from hospital
sources (n = 39)
Isolates from community
sources (n = 41)
Aminoglycosides
Clindamycin 6 (7.5%) 4 (10.3%) 2 (4.9%)a
Gentamicin 11 (13.8%) 4 (10.3%) 7 (17.1%)a
Antifolates
Trimethoprim—sulfamethoxazole 18 (22.5%) 10 (25.6%) 8 (19.5%)
b-lactams
Oxacillin 18 (22.5%) 18 (46.2%) 0a
Penicillin G 48 (60%) 32 (82.1%) 16 (39%)a
Erythromycin 7 (8.8%) 7 (17.9%) 0a
Glycopeptides
Vancomycin 0 0 0
Quinolones
Ciprofloxacin 9 (11.3%) 5 (12.8%) 4 (9.8%)
Tetracyclines
Tetracycline 11 (13.8%) 8 (20.5%) 3 (7.3%)a
Other antibiotics
Chloramphenicol 8 (10%) 5 (12.8%) 3 (7.3%)a
Nitrofurantoin 3 (3.8%) 3 (7.7%) 0a
ap < 0.05 compared to isolates from hospital sources.Results
Eighty isolates of Staphylococcus aureus were recovered
from the specimens, most of which were from urine
(n = 23), high vaginal swabs (n = 12) and abscesses (n = 10).
Forty-one isolates (51%) were from community samples
(Table 1). All positive isolates gave positive reactions in
mannitol salt fermentation, in catalase and tube coagulase
and latex agglutination tests. Sixteen isolates demonstrated
beta hemolysis on horse blood agar while four were variable.
All isolates were susceptible to vancomycin and only three
were resistant to nitrofurantoin. Overall, 62 (77.5%) of theTable 3 Antibiotic resistance profiles for multi-resistant S. aure
Antibiotic Isolate (source)
#9
(Urine)
#12
(Urine)
#14
(Urine)
#24
(HVS)
#4
sw
Clindamycin S R R S R
Gentamicin R R R R S
Trimethoprim—
sulfamethoxazole
S R S S R
Oxacillin R R S R R
Penicillin R R R R R
Erythromycin S R R R S
Vancomycin S S S S S
Ciprofloxacin R R S R R
Tetracycline R R R R R
Chloramphenicol R R R R R
Nitrofurantoin R R S S S
HVS, high vaginal swab; R, resistant; S, susceptible.isolates were resistant to at least one antibiotic, and eight
isolates (10%) were resistant to four or more antibiotics.
Forty-eight (60%) isolates were resistant to penicillin G, 18
(22.5%) each to trimethoprim—sulfamethoxazole and oxacil-
lin, and 11 (13.8%) to tetracycline (Table 2). More isolates
from hospital sources were resistant to the antimicrobials
tested (with the exception of gentamicin). In the majority of
cases, these differences were significant ( p < 0.05). Of
interest was that 82% of hospital isolates were resistant to
penicillin, compared to 39% of community isolates. Further,
all isolates resistant to oxacillin and nitrofurantoin were from
hospital sources. While it was possible for the patients seenus isolates
4 (Wound
ab)
#57 (Wound
abscess)
#64 (Abdominal
aspirate)
#73 (Catheter
tip)
S S R
R R R
S R R
R R R
R R R
R S R
S S S
R R R
R S R
S R R
S S R
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Table 4 Comparison of frequency and percentage rates of resistance to non-b-lactam antibiotics between methicillin-resistant
(MRSA) and methicillin-sensitive S. aureus (MSSA) isolates
Non-b-lactam antibiotics All isolates (n = 80) MRSA (n = 18) MSSA (n = 62)
Clindamycin 6 (7.5%) 4 (22.2%) 2 (3.2%) a
Gentamicin 11 (13.8%) 6 (33.3%) 5 (8.1%) a
Trimethoprim—sulfamethoxazole 18 (22.5%) 6 (33.3%) 12 (19.4%)a
Erythromycin 7 (8.8%) 4 (22.2%) 3 (4.8%) a
Vancomycin 0 0 0
Ciprofloxacin 9 (11.3%) 3 (16.7%) 6 (9.7%)
Tetracycline 11 (13.8%) 6 (33.3%) 5 (8.1%) a
Chloramphenicol 8 (10%) 5 (27.8%) 3 (4.8%) a
Nitrofurantoin 3 (3.8%) 3 (16.7%) 0a
ap < 0.05 compared to MRSA isolates.at private primary care centers to have had some contact
with a hospital, there was no indication of previous hospi-
talization.
The eight multi-resistant isolates were recovered from
urine, high vaginal swab, wound swab, wound abscess,
abdominal abscess, and catheter tip (Table 3). All of these
isolates were resistant to penicillin, and most (87.5%) were
resistant to gentamicin, oxacillin, ciprofloxacin, tetracy-
cline, and chloramphenicol. However, all multiple-resistant
isolates that were susceptible to oxacillin were also suscep-
tible to trimethoprim—sulfamethoxazole, ciprofloxacin,
nitrofurantoin, and vancomycin.
Table 4 shows a comparison of the susceptibilities of MRSA
andMSSA to thenon-b-lactamantimicrobial agents used in this
study. We found that a significantly greater proportion of the
MRSA isolates (compared to the MSSA isolates) were resistant
to these antimicrobials. In particular, those isolates resistant
to nitrofurantoin were MRSA. Of note was that twice as many
MSSA isolates were resistant to trimethoprim—sulfamethox-
azole andciprofloxacin, andalmost equal numbers ofMSSAand
MRSA isolates were resistant to gentamicin, erythromycin and
tetracycline. All MRSA isolates were susceptible to vancomy-
cin. Among antimicrobials used in this study, penicillin showed
the least anti-staphylococcal activity and almost half of the
MSSA isolates were resistant to penicillin.
Discussion
Because of the widespread use of antibiotics, especially in
developing countries, the resistance profile ofmicroorganisms
is changing, evidenced by increasing occurrences of antibiotic
resistance among bacterial populations.15—17 Additionally,
resistance rates are typically higher in developing countries
(with ratesup to99%)18—20 as compared todevelopedcountries
(where ratesare less than20%).21,22Consequently, it is impera-
tive that local surveillance of common pathogenic organisms
and their antibiograms be implemented to advise the current
use of antibiotics. This is essential to the formulation of
prescribing policies based on local statistics.
This study provides important data on current antimicro-
bial resistance, including methicillin resistance, for a collec-
tion of recent clinical isolates of S. aureus from hospital and
community sources in southern Jamaica. We found a 23%
prevalence rate of methicillin (oxacillin) resistance. This
compares with prevalence rates of 43% observed in a studyfrom the USA,23 30% in European countries,24 and up to 54% in
Japan.25 Further, we noted that 82% of the isolates from
hospital sources were resistant to penicillin. This is almost
identical to a previous study26 at the University Hospital of
theWest Indies (UHWI), a 500-bedmulti-disciplinary teaching
hospital, which serves the metropolitan area of Kingston and
St. Andrew. This facility is situated about 124 km from Man-
deville, where our study was conducted. By contrast with
that study, which recorded a similar level of penicillin resis-
tance in isolates from outpatients, we found a 39% preva-
lence in our isolates from community sources. This difference
could be due in part to the increased antimicrobial resistance
associated with teaching hospitals, possibly due to increased
selective pressure arising fromwidespread antimicrobial use,
as well as high density patient population in contact with
healthcare staff and the attendant risk of cross infection.27,28
To further elaborate the distinction between the isolates, the
majority (72%) of resistant isolates in our study were from
hospital patients, suggesting a pattern of antibiotic exposure
among patients in hospitals.
A significant number of S. aureus isolates were recovered
from high vaginal swabs and urine in this study. High vaginal
swab isolates are usually associated with puerperal sepsis or
neglected foreign bodies, and less frequently with bacterial
vaginosis, and significant numbers of MRSA organisms have
been found among these isolates.29—32 While it is likely that
many S. aureus organisms might be passive colonizers or due
to contamination from the skin, some are associated with
complications of pregnancy.31 Although S. aureus is a rare
cause of urinary tract infections, accounting for only 0.5% to
6% of all positive urine cultures,33,34 their finding is increas-
ingly being recognized as significant, especially in patients
with urinary tract catheterization, as under-treatment or
delayed treatment could lead to development of staphylo-
coccal bacteremia.33,35,36
The pattern of antibiotic susceptibility of S. aureus dif-
fered significantly between MSSA and MRSA isolates. Except
for penicillin and to some extent co-trimoxazole, most MSSA
isolates were susceptible to nearly all antimicrobial agents
used in this study. In contrast, in the case of MRSA, multiple-
drug resistance was common and only few antibiotics were
active against these isolates. Chloramphenicol did not show
good activity against MRSA isolates, which is in concert with
the disappointing results of clinical trials that used chlor-
amphenicol for treatment of MRSA infections.37 Clindamycin
224 P.D. Brown, C. Ngenowas active against most MSSA and MRSA isolates (97% and
78%, respectively). There is debate on the efficacy of clin-
damycin as an alternative agent for treatment of infections
caused by S. aureus, due to problems with toxicity and
reports of emergence of resistance during therapy.38 There
are few clinical reports on the use of ciprofloxacin for
treatment of infections caused by MRSA.39 In this study,
we found 17% and 10% of the MRSA and MSSA isolates,
respectively, were resistant to ciprofloxacin. This is of con-
cern because this broad-spectrum antibiotic has only
recently entered clinical use. Co-trimoxazole, like ciproflox-
acin, was not as active as expected against MSSA isolates. The
rate of resistance among MRSA isolates to co-trimoxazole was
high (33%) compared to 20% for MSSA isolates. However, it is
one of the few antibiotics with clinically documented effi-
cacy for treatment of infections caused by susceptible MRSA
isolates.40
This is the first report of MRSA in this region in Jamaica.
Because methicillin resistance is associated with multi-drug
resistance in S. aureus, it is likely that consistent use of
oxacillin as the first-line drug could be the reason for the high
prevalence of MRSA isolates among hospital patients in south-
ern Jamaica. Against this background, methicillin resistance
might be useful as an index for the selection of appropriate
antimicrobial agents for the treatment of infections caused
by S. aureus due to the difference in drug resistance patterns
of hospital vs. community MRSA organisms. While no MRSA
isolate was obtained from community sources in this study, it
is imperative that surveillance initiatives be focused on both
the hospital and community in order to monitor and limit the
spread of this organism.
Conflict of interest: No conflict of interest to declare.
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